Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
-

-

-
-
-
?22.67

?22.67

 
WKN: A2DLUK / Symbol: CBIO / Name: Catalyst Bio / Stock / Pharmaceuticals / Small Cap /
Latest predictions
€21.49
27.08.25
-
buy
€22.23
25.08.25
-
buy
€23.10
14.07.25
-
buy
€24.08
25.06.25
-
buy
24.06.25
-
buy
Your prediction

Catalyst Biosciences Inc Stock

Our community is currently high on Catalyst Biosciences Inc with 5 Buy predictions and 0 Sell predictions.
Based on the current price of 0.52 € the target price of 22 € shows a potential of 4134.84% for Catalyst Biosciences Inc which would more than double the current price.
For the coming years our community has positive and negative things to say abot the Catalyst Biosciences Inc stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Worthwhile Investment for the next years" there were negative voices in the community.

Pros and Cons of Catalyst Biosciences Inc in the next few years

Pros
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
B****
Cons
?
S********** s********
?
M***** P*******
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Catalyst Biosciences Inc vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Catalyst Biosciences Inc - - - - - - -
Pacira Pharmaceuticals -1.820% 1.852% 10.000% 18.919% 18.919% -38.547% -53.586%
Rockwell Medical Inc. -6.560% 2.622% -15.123% -64.087% -64.087% -23.789% -91.106%
Twist Bioscience Corp -1.000% -3.029% 1.016% -39.099% -39.099% 27.402% -75.991%

Comments

Prediction Buy
Perf. (%) -
Target price 21.488
Change
Ends at 27.08.26

Crescent Biopharma (NASDAQ:CBIO) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $25.00 price target on the stock.
Ratings data for CBIO provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -
Target price 22.230
Change
Ends at 25.08.26

Crescent Biopharma (NASDAQ:CBIO) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $26.00 price target on the stock.
Ratings data for CBIO provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -
Target price 23.101
Change
Ends at 14.07.26

Crescent Biopharma, Inc. (NASDAQ: CBIO) is now covered by analysts at Wedbush. They set an "outperform" rating and a $27.00 price target on the stock.
Ratings data for CBIO provided by MarketBeat
Show more